{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:32:49Z","timestamp":1786447969934,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272276"],"award-info":[{"award-number":["82272276"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08598-w","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:44:48Z","timestamp":1786376688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circ17399 RNA promotes melanoma progression through the miR-150-3p\/ITM2C Axis and ALKBH5-mediated FOXM1 m6A modification"],"prefix":"10.1186","volume":"24","author":[{"given":"Ronghua","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deni","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2082-742X","authenticated-orcid":false,"given":"Sitong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"issue":"S1","key":"8598_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40257-018-0373-6","volume":"19","author":"R Cabrera","year":"2018","unstructured":"Cabrera R, Recule F. Unusual Clinical Presentations of Malignant Melanoma: A Review of Clinical and Histologic Features with Special Emphasis on Dermatoscopic Findings. Am J Clin Dermatol. 2018;19(S1):15\u201323. https:\/\/doi.org\/10.1007\/s40257-018-0373-6.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"8598_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.bbcan.2019.02.002","volume":"1871","author":"I Kozar","year":"2019","unstructured":"Kozar I, Margue C, Rothengatter S, et al. Many ways to resistance: How melanoma cells evade targeted therapies. Biochimica et Biophysica Acta (BBA) -. Reviews Cancer. 2019;1871(2):313\u201322. https:\/\/doi.org\/10.1016\/j.bbcan.2019.02.002.","journal-title":"Reviews Cancer"},{"key":"8598_CR3","doi-asserted-by":"publisher","unstructured":"Gide TN, Pires da Silva I, Quek C, et al. Clinical and molecular heterogeneity in patients with innate resistance to anti-PD-1 +\/\u2013 anti-CTLA-4 immunotherapy in metastatic melanoma reveals distinct therapeutic targets. Cancers. 2021;13(13). https:\/\/doi.org\/10.3390\/cancers13133186.","DOI":"10.3390\/cancers13133186"},{"issue":"12","key":"8598_CR4","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s40265-018-0945-z","volume":"78","author":"N Malissen","year":"2018","unstructured":"Malissen N, Grob J-JM, Melanoma. Recent Therapeutic Progress and Future Perspectives. Drugs. 2018;78(12):1197\u2013209. https:\/\/doi.org\/10.1007\/s40265-018-0945-z.","journal-title":"Drugs"},{"key":"8598_CR5","doi-asserted-by":"publisher","unstructured":"Zhang W, Yuan S, Zhang Z, et al. Regulating tumor cells to awaken T cell antitumor function and enhance melanoma immunotherapy. Biomaterials. 2025;316(0). https:\/\/doi.org\/10.1016\/j.biomaterials.2024.123034.","DOI":"10.1016\/j.biomaterials.2024.123034"},{"issue":"0","key":"8598_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2021.02.004","volume":"505","author":"L Chen","year":"2021","unstructured":"Chen L, Shan G. CircRNA in cancer: Fundamental mechanism and clinical potential. Cancer Lett. 2021;505(0):49\u201357. https:\/\/doi.org\/10.1016\/j.canlet.2021.02.004.","journal-title":"Cancer Lett"},{"issue":"1","key":"8598_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/jnr.24356","volume":"98","author":"J Zang","year":"2018","unstructured":"Zang J, Lu D, Xu A. The interaction of circRNAs and RNA binding proteins: An important part of circRNA maintenance and function. J Neurosci Res. 2018;98(1):87\u201397. https:\/\/doi.org\/10.1002\/jnr.24356.","journal-title":"J Neurosci Res"},{"key":"8598_CR8","doi-asserted-by":"publisher","unstructured":"Ma Y, Liu Y, Jiang Z, CircRNAs:. A new perspective of biomarkers in the nervous system. Biomed Pharmacother. 2020;128(0). https:\/\/doi.org\/10.1016\/j.biopha.2020.110251.","DOI":"10.1016\/j.biopha.2020.110251"},{"issue":"4","key":"8598_CR9","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1159\/000493457","volume":"49","author":"J-H He","year":"2018","unstructured":"He J-H, Li Y-G, Han Z-P, et al. The CircRNA-ACAP2\/Hsa-miR-21-5p\/ Tiam1 Regulatory Feedback Circuit Affects the Proliferation, Migration, and Invasion of Colon Cancer SW480 Cells. Cell Physiol Biochem. 2018;49(4):1539\u201350. https:\/\/doi.org\/10.1159\/000493457.","journal-title":"Cell Physiol Biochem"},{"key":"8598_CR10","doi-asserted-by":"publisher","unstructured":"Lin X, Huang C, Chen Z, et al. CircRNA_100876 is upregulated in gastric cancer (GC) and promotes the GC cells\u2019 growth, migration and invasion via miR-665\/YAP1 signaling. Front Genet. 2020;11(0). https:\/\/doi.org\/10.3389\/fgene.2020.546275.","DOI":"10.3389\/fgene.2020.546275"},{"issue":"2","key":"8598_CR11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.bbrc.2018.02.119","volume":"497","author":"Q Zhu","year":"2018","unstructured":"Zhu Q, Lu G, Luo Z, et al. CircRNA circ_0067934 promotes tumor growth and metastasis in hepatocellular carcinoma through regulation of miR-1324\/FZD5\/Wnt\/\u03b2-catenin axis. Biochem Biophys Res Commun. 2018;497(2):626\u201332. https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.119.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7995","key":"8598_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-023-06834-7","volume":"625","author":"D Huang","year":"2023","unstructured":"Huang D, Zhu X, Ye S, et al. Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides. Nature. 2023;625(7995):593\u2013602. https:\/\/doi.org\/10.1038\/s41586-023-06834-7.","journal-title":"Nature"},{"key":"8598_CR13","doi-asserted-by":"publisher","unstructured":"Shang Q, Du H, Wu X, et al. FMRP ligand circZNF609 destabilizes RAC1 mRNA to reduce metastasis in acral melanoma and cutaneous melanoma. J Experimental Clin Cancer Res. 2022;41(1). https:\/\/doi.org\/10.1186\/s13046-022-02357-7.","DOI":"10.1186\/s13046-022-02357-7"},{"issue":"1","key":"8598_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbrc.2018.05.114","volume":"502","author":"W Luan","year":"2018","unstructured":"Luan W, Shi Y, Zhou Z, et al. circRNA_0084043 promote malignant melanoma progression via miR-153-3p\/Snail axis. Biochem Biophys Res Commun. 2018;502(1):22\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2018.05.114.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"8598_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jdermsci.2021.08.005","volume":"103","author":"X Chen","year":"2021","unstructured":"Chen X, Tang Y, Yan J, et al. Circ_0062270 upregulates EPHA2 to facilitate melanoma progression via sponging miR-331-3p. J Dermatol Sci. 2021;103(3):176\u201382. https:\/\/doi.org\/10.1016\/j.jdermsci.2021.08.005.","journal-title":"J Dermatol Sci"},{"issue":"1","key":"8598_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ccell.2019.12.007","volume":"37","author":"D Hanniford","year":"2020","unstructured":"Hanniford D, Ulloa-Morales A, Karz A, et al. Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis. Cancer Cell. 2020;37(1):55\u2013e7015. https:\/\/doi.org\/10.1016\/j.ccell.2019.12.007.","journal-title":"Cancer Cell"},{"issue":"10","key":"8598_CR17","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1080\/1061186x.2025.2530656","volume":"33","author":"S Ahmad","year":"2025","unstructured":"Ahmad S, Shah SNA, Parveen R, et al. Machine learning for genomic profiling and drug discovery in personalised lung cancer therapeutics. J Drug Target. 2025;33(10):1807\u201326. https:\/\/doi.org\/10.1080\/1061186x.2025.2530656.","journal-title":"J Drug Target"},{"issue":"7483","key":"8598_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344\u201352. https:\/\/doi.org\/10.1038\/nature12986.","journal-title":"Nature"},{"issue":"7","key":"8598_CR19","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41374-021-00577-7","volume":"101","author":"K Wu","year":"2021","unstructured":"Wu K, Xu T, Song XD, et al. LncRNA SLCO4A1-AS1 modulates colon cancer stem cell properties by binding to miR-150-3p and positively regulating SLCO4A1. Lab Invest. 2021;101(7):908\u201320. https:\/\/doi.org\/10.1038\/s41374-021-00577-7.","journal-title":"Lab Invest"},{"issue":"2","key":"8598_CR20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.ejso.2020.08.002","volume":"47","author":"K Yugawa","year":"2021","unstructured":"Yugawa K, Yoshizumi T, Mano Y, et al. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p. Eur J Surg Oncol. 2021;47(2):384\u201393. https:\/\/doi.org\/10.1016\/j.ejso.2020.08.002.","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"8598_CR21","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.7150\/ijbs.92994","volume":"20","author":"H Wang","year":"2024","unstructured":"Wang H, Zhao S, Liu H, et al. ALKBH5 facilitates the progression of skin cutaneous melanoma via mediating ABCA1 demethylation and modulating autophagy in an m6A-dependent manner. Int J Biol Sci. 2024;20(5):1729\u201343. https:\/\/doi.org\/10.7150\/ijbs.92994.","journal-title":"Int J Biol Sci"},{"key":"8598_CR22","doi-asserted-by":"publisher","unstructured":"Wei C, Wang B, Peng D, et al. Pan-cancer analysis shows that ALKBH5 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including gliomas. Front Immunol. 2022;13(0). https:\/\/doi.org\/10.3389\/fimmu.2022.849592.","DOI":"10.3389\/fimmu.2022.849592"},{"issue":"4","key":"8598_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","volume":"31","author":"S Zhang","year":"2017","unstructured":"Zhang S, Zhao BS, Zhou A, et al. m 6 A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. Cancer Cell. 2017;31(4):591\u2013e606596. https:\/\/doi.org\/10.1016\/j.ccell.2017.02.013.","journal-title":"Cancer Cell"},{"issue":"3","key":"8598_CR24","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.18632\/aging.202371","volume":"13","author":"L Hao","year":"2021","unstructured":"Hao L, Yin J, Yang H, et al. ALKBH5-mediated m6A demethylation of FOXM1 mRNA promotes progression of uveal melanoma. Aging. 2021;13(3):4045\u201362. https:\/\/doi.org\/10.18632\/aging.202371.","journal-title":"Aging"},{"key":"8598_CR25","doi-asserted-by":"publisher","unstructured":"Dong Y, Gao Q, Chen Y, et al. Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy. Nat Commun. 2023;14(1). https:\/\/doi.org\/10.1038\/s41467-023-38232-y.","DOI":"10.1038\/s41467-023-38232-y"},{"issue":"0","key":"8598_CR26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.canlet.2016.12.006","volume":"388","author":"J Chen","year":"2017","unstructured":"Chen J, Li Y, Zheng Q, et al. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer. Cancer Lett. 2017;388(0):208\u201319. https:\/\/doi.org\/10.1016\/j.canlet.2016.12.006.","journal-title":"Cancer Lett"},{"issue":"1","key":"8598_CR27","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/jcb.26201","volume":"119","author":"H Pan","year":"2017","unstructured":"Pan H, Li T, Jiang Y, et al. Overexpression of Circular RNA ciRS-7 Abrogates the Tumor Suppressive Effect of miR\u20107 on Gastric Cancer via PTEN\/PI3K\/AKT Signaling Pathway. J Cell Biochem. 2017;119(1):440\u20136. https:\/\/doi.org\/10.1002\/jcb.26201.","journal-title":"J Cell Biochem"},{"key":"8598_CR28","doi-asserted-by":"publisher","unstructured":"Meng L, Chang S, Sang Y, et al. Circular RNA circCCDC85A inhibits breast cancer progression via acting as a miR-550a-5p sponge to enhance MOB1A expression. Breast Cancer Res. 2022;24(1). https:\/\/doi.org\/10.1186\/s13058-021-01497-6.","DOI":"10.1186\/s13058-021-01497-6"},{"key":"8598_CR29","doi-asserted-by":"publisher","unstructured":"Chen H-H, Zhang T-N, Wu Q-J, et al. Circular RNAs in lung cancer: recent advances and future perspectives. Front Oncol. 2021;11(0). https:\/\/doi.org\/10.3389\/fonc.2021.664290.","DOI":"10.3389\/fonc.2021.664290"},{"key":"8598_CR30","doi-asserted-by":"publisher","unstructured":"Guo Y, Yang J, Huang Q, et al. Circular RNAs and their roles in head and neck cancers. Mol Cancer. 2019;18(1). https:\/\/doi.org\/10.1186\/s12943-019-1003-5.","DOI":"10.1186\/s12943-019-1003-5"},{"key":"8598_CR31","doi-asserted-by":"publisher","unstructured":"Cardamone G, Paraboschi EM, Sold\u00e0 G, et al. The circular RNA landscape in multiple sclerosis: Disease-specific associated variants and exon methylation shape circular RNA expression profile. Multiple Scler Relat Disorders. 2023;69(0). https:\/\/doi.org\/10.1016\/j.msard.2022.104426.","DOI":"10.1016\/j.msard.2022.104426"},{"key":"8598_CR32","doi-asserted-by":"publisher","unstructured":"Luo Y-H, Yang Y-P, Chien C-S, et al. Plasma level of circular RNA hsa_circ_0000190 correlates with tumor progression and poor treatment response in advanced lung cancers. Cancers. 2020;12(7). https:\/\/doi.org\/10.3390\/cancers12071740.","DOI":"10.3390\/cancers12071740"},{"key":"8598_CR33","doi-asserted-by":"publisher","unstructured":"Liu W, Niu J, Huo Y, et al. Role of circular RNAs in cancer therapy resistance. Mol Cancer. 2025;24(1). https:\/\/doi.org\/10.1186\/s12943-025-02254-5.","DOI":"10.1186\/s12943-025-02254-5"},{"key":"8598_CR34","doi-asserted-by":"publisher","unstructured":"Ashrafizadeh M, Dai J, Torabian P, et al. Circular RNAs in EMT-driven metastasis regulation: modulation of cancer cell plasticity, tumorigenesis and therapy resistance. Cell Mol Life Sci. 2024;81(1). https:\/\/doi.org\/10.1007\/s00018-024-05236-w.","DOI":"10.1007\/s00018-024-05236-w"},{"issue":"1","key":"8598_CR35","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13046-022-02378-2","volume":"41","author":"Y Liu","year":"2022","unstructured":"Liu Y, Song J, Zhang H, et al. EIF4A3-induced circTOLLIP promotes the progression of hepatocellular carcinoma via the miR-516a-5p\/PBX3\/EMT pathway. J Experimental Clin Cancer Res. 2022;41(1):164. https:\/\/doi.org\/10.1186\/s13046-022-02378-2.","journal-title":"J Experimental Clin Cancer Res"},{"issue":"1","key":"8598_CR36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jaci.2021.10.041","volume":"150","author":"X Wang","year":"2022","unstructured":"Wang X, Xu C, Cai Y, et al. CircZNF652 promotes the goblet cell metaplasia by targeting the miR-452-5p\/JAK2 signaling pathway in allergic airway epithelia. J Allergy Clin Immunol. 2022;150(1):192\u2013203. https:\/\/doi.org\/10.1016\/j.jaci.2021.10.041.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"8598_CR37","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1158\/1078-0432.Ccr-22-3836","volume":"29","author":"N Ding","year":"2023","unstructured":"Ding N, You AB, Yang H, et al. A Tumor-suppressive Molecular Axis EP300\/circRERE\/miR-6837-3p\/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer. Clin Cancer Res. 2023;29(11):2095\u2013109. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-22-3836.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"8598_CR38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12935-023-03105-3","volume":"23","author":"A Ameri","year":"2023","unstructured":"Ameri A, Ahmed HM, Pecho RDC, et al. Diverse activity of miR-150 in Tumor development: shedding light on the potential mechanisms. Cancer Cell Int. 2023;23(1):261. https:\/\/doi.org\/10.1186\/s12935-023-03105-3.","journal-title":"Cancer Cell Int"},{"key":"8598_CR39","doi-asserted-by":"publisher","unstructured":"Tan Z, Jia J, Jiang Y. MiR-150-3p targets SP1 and suppresses the growth of glioma cells. Biosci Rep. 2018;38(3). https:\/\/doi.org\/10.1042\/bsr20180019.","DOI":"10.1042\/bsr20180019"},{"issue":"3","key":"8598_CR40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41419-021-03554-6","volume":"12","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Zhou X, Wan M, et al. FoxP3-miR-150-5p\/3p suppresses ovarian tumorigenesis via an IGF1R\/IRS1 pathway feedback loop. Cell Death Dis. 2021;12(3):275. https:\/\/doi.org\/10.1038\/s41419-021-03554-6.","journal-title":"Cell Death Dis"},{"key":"8598_CR41","doi-asserted-by":"publisher","unstructured":"Maurya NS, Kushwaha S, Vetukuri RR, et al. Unlocking the potential of the CA2, CA7, and ITM2C gene signatures for the early detection of colorectal cancer: a comprehensive analysis of RNA-Seq data by utilizing machine learning algorithms. Genes. 2023;14(10). https:\/\/doi.org\/10.3390\/genes14101836.","DOI":"10.3390\/genes14101836"},{"key":"8598_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/blctt.S461529","volume":"14","author":"N Mei","year":"2024","unstructured":"Mei N, Gong S, Wang L, et al. Identification of a Prognostic Model Based on NK Cell-Related Genes in Multiple Myeloma Using Single-Cell and Transcriptomic Data Analysis. Blood Lymphatic Cancer: Targets Therapy. 2024;14:31\u201348. https:\/\/doi.org\/10.2147\/blctt.S461529.","journal-title":"Blood Lymphatic Cancer: Targets Therapy"},{"issue":"1","key":"8598_CR43","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13046-024-03073-0","volume":"43","author":"X Hua","year":"2024","unstructured":"Hua X, Xu Q, Wu R, et al. ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages. J Experimental Clin Cancer Res. 2024;43(1):164. https:\/\/doi.org\/10.1186\/s13046-024-03073-0.","journal-title":"J Experimental Clin Cancer Res"},{"issue":"1","key":"8598_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12943-020-01239-w","volume":"19","author":"Y Chen","year":"2020","unstructured":"Chen Y, Zhao Y, Chen J, et al. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1. Mol Cancer. 2020;19(1):123. https:\/\/doi.org\/10.1186\/s12943-020-01239-w.","journal-title":"Mol Cancer"},{"issue":"22","key":"8598_CR45","doi-asserted-by":"publisher","first-page":"13625","DOI":"10.1093\/nar\/gkae988","volume":"52","author":"C-C Hsu","year":"2024","unstructured":"Hsu C-C, Yao X, Chen S-Y, et al. The conformation of FOXM1 homodimers in vivo is crucial for regulating transcriptional activities. Nucleic Acids Res. 2024;52(22):13625\u201343. https:\/\/doi.org\/10.1093\/nar\/gkae988.","journal-title":"Nucleic Acids Res"},{"issue":"0","key":"8598_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2023.03.007","volume":"92","author":"MA Khan","year":"2023","unstructured":"Khan MA, Khan P, Ahmad A, et al. FOXM1: A small fox that makes more tracks for cancer progression and metastasis. Sem Cancer Biol. 2023;92(0):1\u201315. https:\/\/doi.org\/10.1016\/j.semcancer.2023.03.007.","journal-title":"Sem Cancer Biol"},{"key":"8598_CR47","doi-asserted-by":"publisher","unstructured":"Madhi H, Lee JS, Choi YE, et al. FOXM1 inhibition enhances the therapeutic outcome of lung cancer immunotherapy by modulating PD-L1 expression and cell proliferation. Adv Sci. 2022;9(29). https:\/\/doi.org\/10.1002\/advs.202202702.","DOI":"10.1002\/advs.202202702"},{"key":"8598_CR48","doi-asserted-by":"publisher","unstructured":"Zhang S, Wang J, Hu W, et al. RNF112-mediated FOXM1 ubiquitination suppresses the proliferation and invasion of gastric cancer. JCI Insight. 2023;8(11). https:\/\/doi.org\/10.1172\/jci.insight.166698.","DOI":"10.1172\/jci.insight.166698"},{"issue":"12","key":"8598_CR49","doi-asserted-by":"publisher","first-page":"e0144241","DOI":"10.1371\/journal.pone.0144241","volume":"10","author":"S Chen","year":"2015","unstructured":"Chen S, Miyashita A, Fukushima S, et al. Investigation of FOXM1 as a Potential New Target for Melanoma. PLoS ONE. 2015;10(12):e0144241. https:\/\/doi.org\/10.1371\/journal.pone.0144241.","journal-title":"PLoS ONE"},{"issue":"6","key":"8598_CR50","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.jid.2017.01.021","volume":"137","author":"JA Puig-Butille","year":"2017","unstructured":"Puig-Butille JA, Vinyals A, Ferreres JR, et al. AURKA Overexpression Is Driven by FOXM1 and MAPK\/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy. J Invest Dermatology. 2017;137(6):1297\u2013310. https:\/\/doi.org\/10.1016\/j.jid.2017.01.021.","journal-title":"J Invest Dermatology"},{"issue":"3","key":"8598_CR51","doi-asserted-by":"publisher","first-page":"e0344028","DOI":"10.1371\/journal.pone.0344028","volume":"21","author":"P Singh","year":"2026","unstructured":"Singh P, Ahmad S, Qazi S, et al. Multitarget docking and molecular enumeration reveal DdpMPyPEPhU as a potent modulator of cell cycle, glucocorticoid, and estrogen signalling in breast cancer. PLoS ONE. 2026;21(3):e0344028. https:\/\/doi.org\/10.1371\/journal.pone.0344028.","journal-title":"PLoS ONE"},{"issue":"3","key":"8598_CR52","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3390\/ijms26031060","volume":"26","author":"AP Singh","year":"2025","unstructured":"Singh AP, Ahmad S, Roy A, et al. Investigating the Inhibitory Effects of Paliperidone on RAGEs: Docking, DFT, MD Simulations, MMPBSA, MTT, Apoptosis, and Immunoblotting Studies. Int J Mol Sci. 2025;26(3):1060. https:\/\/doi.org\/10.3390\/ijms26031060.","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08598-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08598-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08598-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T10:50:37Z","timestamp":1786445437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08598-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8598"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08598-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research has been approved by the Medical Ethics Committee of the First People\u2019s Hospital of Foshan City. All animal experiments were conducted in accordance with the animal experiment ethics guidelines of the First People\u2019s Hospital of Foshan City.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no competing interest exists.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1028"}}